1 november 2009
Sanofi-aventis acquires Kernpharm and gains entry to the Dutch OTC market
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.
Hans van Nuland, the Managing Director of Kernpharm: “Sanofi-aventis was the best acquisition partner for us.
The company has a very clear and effective strategy for the Dutch market, which will help Kernpharm make the transition to a new phase in its history.
Do you want to read the whole press release, download the press release down here.
